ALX-0600 ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
96クローン病2

96. クローン病


臨床試験数 : 2,442 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00308438
(ClinicalTrials.gov)
March 1, 200413/9/2005Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008Crohn's DiseaseDrug: Teduglutide (ALX-0600)ShireNULLCompleted18 YearsN/AAll67Phase 2United States;Canada
2NCT00072839
(ClinicalTrials.gov)
November 12, 200311/11/2003Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's DiseaseA Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's DiseaseCrohn's DiseaseDrug: ALX-0600;Drug: placebo;Drug: teduglutide 0.05;Drug: teduglutide 0.2 mg;Drug: Teduglutide 0.05 dose;Drug: teduglutide 0.1 mg doseShireNULLCompleted18 YearsN/AAll100Phase 2United States;Canada